FDA Allows Mass Production of Stem Cells For Clinical Trials

Jul
17
2018
Regenerative Medicine witnessed a giant leap towards the future when the U.S. Food and Drug Administration (FDA) has finally granted the permission for the production of automated stem cells in large quantities. Stem Cells, which are the basic building blocks of the human body, have the ability to regenerate and replicate to become any specialised type of cells. They are known to have the potential to promote tissue repair and healing of several tissues, including bone, heart, and brain.

With the exponential increase of the quantities of stem cells, this initiative by FDA will pave ways for significant medical advancement. First, it could rise as the solution for cells insufficiency. The current Stem Cell production has long been a time-consuming and a labor-intensive process, in which researchers must carefully cultivate hundreds of flasks only to produce enough stem cells for a few patients. The surplus of the supplies now means Stem Cell treatment for a wide-range of conditions is made available for patients even on a short notice.

Stem Cells possess the ability of regenerating and developing into any cell, organ or tissue of specific function. It is also one of the most practical and effective way to repair cell damage and treat fatal injuries or cell degeneration in different body parts. Stem Cell Treatment with Verita Neuro has shown potential in treating many degenerative conditions. Please contact us for more information about the treatments and supportive therapies.
Global Stem Cells July 17, 2018 October 17, 2018 (16299) (0)
Tags:

Cellular Treatment

Stem Cell Research

Stem Cell Treatment
Categories:

Misc.
About author

Global Stem Cells

FDA Allows Mass Production of Stem Cells For Clinical Trials

Contact a Stem Cell Treatment Specialist Now!

Our Patient Representatives are available to introduce and to fully explain your Stem Cell treatment options. Consult with an experienced Stem Cell doctor at no charge.

English

Like all medical procedures, Stem Cell Treatments have a success and failure rate. No guarantees or claim of cures are made as to the extent of the response to the treatments promoted by globalstemcells.com. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else. This website is not intended as a substitute for the diagnosis, conventional treatments and advice of your physician. The Stem Cell Treatments promoted on this page are currently not FDA approved and not part of a FDA-regulated clinical investigation. globalstemcells.com and Verita Neuro Pte. Ltd. educate and facilitate access to medical treatments and services for patients who have exhausted all other conventional treatment options. The promoted treatments are based on independent third party clinical evidence.

FDA Allows Mass Production of Stem Cells For Clinical Trials

Contact a Stem Cell Treatment Specialist Now!

CONTACT INFO

FOLLOW US

Highlighted Treatable Conditions

Visual Impairment

Not Listed Medical Conditions

FDA Allows Mass Production of Stem Cells For Clinical Trials

Contact a Stem Cell Treatment Specialist Now!

CONTACT INFO

FOLLOW US